Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Acq. announced CC transcript
|
KING PHARMACEUTICALS INC (KG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/08/2011 |
MW
| King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange |
01/31/2011 |
MW
| King Pharmaceuticals, Inc. Announces Offer to Purchase Any and All of Its Outstanding 1 1/4% Convertible Senior Notes Due 2026 Through a Tender Offer |
10/13/2010 |
BW
| The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of King Pharmaceuticals, Inc. in Connection with the Sale of the Company to Pfizer, Inc. – KG |
10/12/2010 |
BW
| Levetown & Jenkins, LLP Announces an Investigation of the Acquisition of King Pharmaceuticals, Inc. by Pfizer, Inc. |
10/12/2010 |
BW
| Law Office of Brodsky & Smith, LLC Announces Investigation of King Pharmaceuticals |
10/12/2010 |
BW
| Finkelstein Thompson LLP Announces Investigation of King Pharmaceuticals Inc. |
10/12/2010 |
BW
| Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of King Pharmaceuticals, Inc. |
10/12/2010 |
BW
| Ryan & Maniskas, LLP Announces Investigation of King Pharmaceuticals Inc. |
10/12/2010 |
BW
| The Law Office of Robbins Umeda LLP Announces an Investigation of the Acquisition of King Pharmaceuticals, Inc. by Pfizer, Inc. |
10/12/2010 |
BW
| King Pharmaceuticals Buyout Investigated for Shareholders by Goldfarb Branham Law Firm LLP |
10/12/2010 |
BW
| The Briscoe Law Firm Investigates King Pharmaceuticals, Inc. for Shareholders Concerning the Buy-Out by Pfizer Inc. |
|
|